ISLAMABAD, Dec 1: Several essential medicines are out of market ostensibly because of an artificial shortage created by their multinational manufacturers in a bid to extract maximum concessions from the government ahead of finalisation of its drug pricing policy.

The crisis is being described by some people in medical circles as the worst in recent years because even some of the most common medicines like Panadol have disappeared from chemists’ shelves across the country, and stocks of several prescription drugs manufactured by multinationals in different parts of the country have rapidly depleted. Included among these are Augmentin and Wymox capsules, Mucaine syrup, Ventolin inhaler, Actifed, Betnovate-N cream, Polyfax ointments (skin & eye), Pyodine, Polycrol syrup, Gaviscone syrup, Angisid tablets, Thyroxine, Atem inhaler, Neomercazole, Cicatrin power, Distalgesic tablets, Septran syrup, Amoxil capsules and Buscopan, Maxolon, and Gravinate tablets. The list is by no means exhaustive.

Most of these drugs are on WHO’s list of essential medicines.

Salespersons in Islamabad’s leading chemist stores confirmed that most of the drugs had been short in supply for sometime. Mr M. Fazal of the Shaheen Chemists said the drugs had been either in short supply or not available at all.

Mohammad Hussain, who works at the D. Watson Chemists, said the shortage had been there for quite a few weeks.

Sources in the pharmaceutical industry indicated that it was an artificial shortage created by manufacturers in anticipation of a new official pricing formula for medicines. The new formula is expected to be announced by the end of this month and is likely to significantly raise prices.

According to sources, some multinational companies have slowed down production and it was a pre-planned shortage.

The companies, a senior health ministry official said, were eyeing a massive 35 per cent hike in prices.

Former Pharma Bureau chief Jeurgen Konig had indicated in an interview with Dawn in June that the multinational companies might cut the supply of their products if they did not get a price hike from the health ministry.

There has been no official increase in the prices of drugs since December, 2001.

However, despite regulatory restrictions local pharmaceutical companies have on a number of occasions enhanced prices of their products. The last raise of some 5 per cent was made late last month.

The tactics of multinational companies have already started yielding desired results.

Health Ministry’s Director General Dr Rashid Juma told Dawn that the new formula would provide ‘relief’ on the old registered drugs of multinational companies.

Qaiser Waheed, one of the leaders of the Pakistan Pharmaceutical Manufacturers Association, an umbrella organisation of local manufacturers, says that the situation has aggravated because of excessive reliance by doctors on drugs produced by multinationals.

Opinion

Editorial

China security ties
Updated 14 Nov, 2024

China security ties

If China's security concerns aren't addressed satisfactorily, it may affect bilateral ties. CT cooperation should be pursued instead of having foreign forces here.
Steep price
14 Nov, 2024

Steep price

THE Hindu Kush-Himalayan region is in big trouble. A new study unveiled at the ongoing COP29 reveals that if high...
A high-cost plan
14 Nov, 2024

A high-cost plan

THE government has approved an expensive plan for FBR in the hope of tackling its deep-seated inefficiencies. The...
United stance
Updated 13 Nov, 2024

United stance

It would've been better if the OIC-Arab League summit had announced practical measures to punish Israel.
Unscheduled visit
13 Nov, 2024

Unscheduled visit

Unusual IMF visit shows the lender will closely watch implementation of programme goals to prevent it from derailing.
Bara’s businesswomen
13 Nov, 2024

Bara’s businesswomen

Bara’s brave women have proven that with the right support, societal barriers can be overcome.